Showing results (611-620 of 1,372) with videos related to

Sort By:
Pageof 138
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 23, 2026
Quantitative assessment of brain atrophy in bvFTD: Implications for diagnostic conversionChloe Beydoun, Halle Quang, Sophie Matis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 8, 2026
The influence of bilingualism on the assessment and treatment of an Italian-English speaker with the logopenic variant of PPARoberta Tomasoni, Gaia C Santi, Serena Tagliente, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 8, 2026
Application of machine learning to blood-based biomarkers of Alzheimer's disease in Down syndromePatrick H Luckett, Melissa Petersen, Sid O'Bryant, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 13, 2026
Subjective memory concerns and AD/ADRD plasma biomarker associations in HABS-HDKelsey R Thomas, Caitlin M Terao, Alexandra J Weigand, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 14, 2026
Inter-software variability of Centiloid quantification in amyloid PET: A head-to-head comparison of five software platformsJun Zhang, Brian J Burkett, Christopher G Schwarz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 15, 2026
Automated differentiation of non-fluent and logopenic primary progressive aphasia in Italian speakers using acoustic and linguistic speech measuresFrancesco Pierotti, Carmen Morinelli, Valentina Moschini, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 13, 2026
Real-world implementation of lecanemab in Korean patients at a tertiary memory clinic: Safety, ARIA risk, and early treatment patternsJaemin Shin, Sang-Il Suh, Yu Jeong Park, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 19, 2026
Harmonizing biofluid specimen collection and biomarker quantification in Diverse Vascular Contributions to Cognitive Impairment and Dementia (DVCID) studySitong Zhou, Jacob Conston, Nopparat Suthprasertporn, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 19, 2026
Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysisCindy David Sarmento, Gabin Drouard, Toni T Saari, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 19, 2026
Experience with donanemab over a 1-year period: observations of side effects and compliance from a regional specialty medical centerLisa B E Shields, Hannah S Hust, Gregory E Cooper, et al.
Pageof 138